• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Innate Pharma SA to Release FY2025 Q3 Earnings on November 13 Pre-Market EST, Forecast Revenue USD 2.324 M, EPS USD -0.142
00:24
Oct28
Innate Pharma SA Outlines Strategy and Pipeline for Next-Generation Antibody Cancer Therapies
12:13
Sep17
Innate Pharma SA released FY2025 Semi-Annual Earnings on September 17 Pre-Market EST, actual revenue USD 5.475 M (forecast USD 12.23 M), actual EPS USD -0.2816 (forecast USD -0.35)
13:30
Innate Pharma SA released FY2025 Q1 earnings on September 17 Pre-Market EST, actual revenue USD 2.63 M, actual EPS USD -0.1353
13:30
Innate Pharma SA released FY2025 Q2 earnings on September 17 Pre-Market (EST), actual revenue USD 2.844 M, actual EPS USD -0.1436
13:30
Sep9
Innate Pharma SA to Release FY2025 Semi-Annual Earnings on September 16, 2025 (EST), Forecast Revenue USD 12.27 M, EPS USD -0.35
00:10

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release

Sep17
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.844 M, Net Income -12.49 M, EPS -0.1463

May13
Earning Release(EST)

FY2025 Q1 Earning Release

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More